SARS-CoV-2 Nucleocapsid antibody
Quick Overview for SARS-CoV-2 Nucleocapsid antibody (ABIN7478577)
Target
See all SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Specific for the nucleoprotein of the SARS virus (IFA, ELISA & WB) and COVID-19 virus (ELISA)
-
Cross-Reactivity (Details)
- All of these antibodies are reactive with the NP of COVID-19 virus by ELISA. They are all negative for human coronaviruses 229E & OC43, All antibodies are reactive with the nucleocapsids of Variants: UK B.1.1.7, SA B.1.351, Brazil P.1 & B.1.617.2
-
Purification
- purified preparations consist of >90% pure mouse monoclonal antibody which has been purified from ascites fluid or culture medium by protein A chromatography or sequential differential precipitations.
-
Purity
- >90 %
-
Isotype
- IgG1
-
-
-
-
Application Notes
- 1:20-1:200 for ELISA,1:10-1:50 for IFA, Specific for the nucleoprotein of the SARS virus (IFA, ELISA & WB) and COVID-19 virus (ELISA)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 100 μg/mL
-
Buffer
- 0.01 M phosphate buffered saline, pH 7.2 and contains 0.1 % sodium azide. This product contains no stabilizing proteins
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- stored at 2-8°C
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Alternative Name
- SARS-CoV-2 Nucleocapsid
-
Target Type
- Viral Protein
Target
-